Reliance upon ancestral mutations is maintained in colorectal cancers that heterogeneously evolve during targeted therapies

Attempts at eradicating metastatic cancers with targeted therapies are limited by the emergence of resistant subclones bearing heterogeneous (epi)genetic changes. We used colorectal cancer (CRC) to test the hypothesis that interfering with an ancestral oncogenic event shared by all the malignant cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Russo, Mariangela, Lamba, Simona, Lorenzato, Annalisa, Sogari, Alberto, Corti, Giorgio, Rospo, Giuseppe, Mussolin, Benedetta, Montone, Monica, Lazzari, Luca, Arena, Sabrina, Oddo, Daniele, Linnebacher, Michael, Sartore-Bianchi, Andrea, Pietrantonio, Filippo, Siena, Salvatore, Di Nicolantonio, Federica, Bardelli, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997733/
https://www.ncbi.nlm.nih.gov/pubmed/29895949
http://dx.doi.org/10.1038/s41467-018-04506-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997733/
https://www.ncbi.nlm.nih.gov/pubmed/29895949
http://dx.doi.org/10.1038/s41467-018-04506-z

Ejemplares similares